Nutex Health
NUTX
26 hedge funds and large institutions have $1.6M invested in Nutex Health in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 22 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
0.47% more ownership
Funds ownership: 0.07% → 0.54% (+0.47%)
45% less funds holding
Funds holding: 47 → 26 (-21)
77% less capital invested
Capital invested by funds: $7.07M → $1.6M (-$5.47M)
91% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.1K |
| 2 |
Renaissance Technologies
New York
|
+$33.5K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$15.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$10.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
-$3.22M |
| 2 |
BHWM
Beaird Harris Wealth Management
Dallas,
Texas
|
-$74.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$34K |
| 4 |
Millennium Management
New York
|
-$9.14K |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.05K |
NUTX Hedge Fund Activity: Q2 2024 in Review
26 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q2 2024, worth a combined $1.6M — down 77% from $7.07M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of NUTX and 2 opened new positions — a net loss of 20 holders — while 5 trimmed existing stakes and 9 added.
The largest buyer was Vanguard Group, adding an estimated $39.1K. The largest seller was Highbridge Capital Management, exiting entirely with an estimated $3.22M sold.
- 26 institutional investors held Nutex Health (NUTX) as of Q2 2024, down from 47 in Q1 2024.
- Funds reported $1.6M of Nutex Health stock for Q2 2024, down 77% quarter-over-quarter.
- 2 funds opened new Nutex Health positions in Q2 2024 and 22 closed out, a net change of -20 holders.
- The largest Nutex Health buyer in Q2 2024 was Vanguard Group, an estimated $39.1K added.
- The largest Nutex Health seller in Q2 2024 was Highbridge Capital Management, an estimated $3.22M sold.
Based on aggregated 13F filings for Q2 2024.